Transcriptomic and epigenomic consequences of heterozygous loss of function mutations in AKAP11, the first large-effect shared risk gene for bipolar disorder and schizophrenia
Preprint in bioRxiv (March 2024)
The most recent citing publications are shown below. View all 36 publications that cite this research output on Dimensions.
Transcriptome profiling as a biological marker for bipolar disorder sub-phenotypes
Article in Advances in Medical Sciences (February 2024)
Molecular signatures of hyperexcitability and lithium responsiveness in bipolar disorder patient neurons provide alternative therapeutic strategies
Preprint in bioRxiv (July 2023)